Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Correlation between lymphocyte counts and PD-L1 immune-related adverse events.
Zachary Sawyer, Mark Sorial, Justin C Liauw
Published: 202610.1177/10781552251415528
Abstract
IntroductionImmune checkpoint inhibitors have improved outcomes for solid tumors but are associated with immune-related adverse events (irAEs). Literature suggests that patients with an absolute lymphocyte count (ALC) ≥ 2000 cells/mm3 prior to treatm…
Preview only. Read the full abstract at the source